NCT07199348View on ClinicalTrials.gov

A Safety and Performance Study of the Use of EmboBio for the Intra-arterial Treatment of Abdominopelvic Bleeding

NANot yet recruitingINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

April 30, 2027

Conditions

Abdomino-pelvic SurgeryBleedingEmbolization

Interventions

DEVICE

Embobio

Embolization with the device Embobio

Sponsors

Lead Sponsor

Embobio Medical

All Listed Sponsors

lead

Embobio Medical

INDUSTRY

NCT07199348 - A Safety and Performance Study of the Use of EmboBio for the Intra-arterial Treatment of Abdominopelvic Bleeding | Biotech Hunter | Biotech Hunter